Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic

Author:

Catalano Alessia1ORCID,Iacopetta Domenico2ORCID,Ceramella Jessica2,Pellegrino Michele2,Giuzio Federica3,Marra Maria2,Rosano Camillo4ORCID,Saturnino Carmela3ORCID,Sinicropi Maria Stefania2ORCID,Aquaro Stefano2

Affiliation:

1. Department of Pharmacy-Drug Sciences, University of Bari Aldo Moro, Via Orabona 4, 70126 Bari, Italy

2. Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy

3. Department of Science, University of Basilicata, 85100 Potenza, Italy

4. Proteomics and Mass Spectrometry Unit, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy

Abstract

Antibacterial resistance is a renewed public health plague in modern times, and the COVID-19 pandemic has rekindled this problem. Changes in antibiotic prescribing behavior, misinformation, financial hardship, environmental impact, and governance gaps have generally enhanced the misuse and improper access to antibiotics during the COVID-19 pandemic. These determinants, intersected with antibacterial resistance in the current pandemic, may amplify the potential for a future antibacterial resistance pandemic. The occurrence of infections with multidrug-resistant (MDR), extensively drug-resistant (XDR), difficult-to-treat drug-resistant (DTR), carbapenem-resistant (CR), and pan-drug-resistant (PDR) bacteria is still increasing. The aim of this review is to highlight the state of the art of antibacterial resistance worldwide, focusing on the most important pathogens, namely Enterobacterales, Acinetobacter baumannii, and Klebsiella pneumoniae, and their resistance to the most common antibiotics.

Funder

Project HORIZON EUROPE SEEDS ID S17 “Tutela della libertà e contrasto delle pandemie

Scienza e diritto per la definizione delle strategie per il contenimento delle situazioni di contagio”—NextgenerationEU Programma MUR—Fondo promozione e sviluppo

BY-COVID Project funding from the European Union’s Horizon Europe Research and Innovation Programme

PRIN

MUR, Italy

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference193 articles.

1. Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election;Strathdee;Lancet,2020

2. World Health Organization (2023, June 20). Global Action Plan on Antimicrobial Resistance, Available online: https://apps.who.int/iris/handle/10665/193736.

3. World Health Organization (2022). One Health Joint Plan of Action (2022–2026): Working Together for the Health of Humans, Animals, Plants and the Environment.

4. A new One Health Joint Action Plan;Jesudason;Lancet Infect. Dis.,2022

5. Tackling AMR from a multidisciplinary perspective: A primer from education and psychology;Carrilero;Int. Microbiol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3